ADAMS, JULIAN,BEHNKE, MARK L.,CASTRO, ALFREDO C.,EVANS, CATHERINE A.,GRENIER, LOUIS,GROGAN, MICHAEL J.,LIU, TAO,SNYDER, DANIEL A.,TIBBITTS, THOMAS T.
申请号：
CA2666224
公开号：
CA2666224C
申请日:
2007.10.10
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a provided compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH in a patient by administering a therapeutically effective amount of a compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof.
